Browsing byAuthorBoland, EG

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2 to 8 of 8< previous 
Issue DateTitleAuthor(s)
2023Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction.Bravington, A; Obita, G; Baddeley, E; Johnson, MJ; Murtagh, FEM; Currow, DC; Boland, EG; Nelson, A; Seddon, K; Oliver, A; Noble, SIR; Boland, JW; Gilchrist, FJ
2017-11-01Effect of Opioids and Benzodiazepines on Clinical Outcomes in Patients Receiving Palliative Care: An Exploratory AnalysisBoland, JW; Allgar, V; Boland, EG; Oviasu, O; Agar, M; Currow, DC; Johnson, MJ
2023-03-14High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction.Boland, JW; Boland, EG; Currow, DC
2017-03-01O-3 Opioids, benzodiazepines, anti-cholinergic load and clinical outcomes in patients with advanced cancerBoland, JW; Allgar, V; Boland, EG; Oviasu, O; Agar, M; Currow, DC; Johnson, MJ
2016-12-01Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic ReviewObita, GP; Boland, EG; Currow, DC; Johnson, MJ; Boland, JW
2022-06Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review.Baddeley, E; Mann, M; Bravington, A; Johnson, MJ; Currow, D; Murtagh, FEM; Boland, EG; Obita, G; Oliver, A; Seddon, K; Nelson, A; Boland, JW; Noble, SIR
2022-10The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review.Bravington, A; Obita, G; Baddeley, E; Johnson, MJ; Murtagh, FE; Currow, DC; Boland, EG; Nelson, A; Seddon, K; Oliver, A; Noble, SI; Boland, JW